OncoStatyx

OncoStatyx is a preclinical-stage drug discovery and development company. Founded in 2013 and headquartered in Cleveland, Ohio, OncoStatyx focuses on developing affordable, safe, and orally bioavailable small-molecule therapeutic agents with the potential to treat various solid tumor cancers, such as breast cancer, prostate cancer, lung cancer, and colorectal cancer.